Mission Bio’s Tapestri Platform is empowering cancer researchers to ask and explore questions that were previously inconceivable. From deciphering the order of mutation acquisition to accurately measuring genomics changes like SNVs and CNVs across thousands of individual cells, Tapestri is bringing a new standard of clarity cancer research. By connecting genotype to phenotype at the single-cell level, you can gain comprehensive insights into disease progression, development of resistance, and minimal residual disease (MRD).
Visit us at EHA (Booth 442) and join us on Saturday evening for an evening with food drinks and scientific conversations.
Join us on Saturday, June 11th at the historic Wiener Rathauskeller for an evening of Viennese wine and food and scientific discussions.
We’ll be joined by Mission Bio’s Chief Medical Officer, Todd Druley, MD, PhD and Sr. Director, Clinical Applications, Aaron Llanso, PhD who will share the latest advancements in single-cell DNA sequencing, particularly in the field of single-cell Minimal Residual Disease (scMRD), Clonal Hematopoiesis, and Therapeutic Resistance.
19.30h Opening of the event (Refreshments will be served)
20.00h Welcome and Introduction by Todd Druley, CMO, Mission Bio
20.30h Networking - Food & drinks will be served
Address: Wiener Rathauskeller, Rathauspl. 1, 1010 Wien
Space is limited. Save your spot today by submitting the form on the right.